Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem Cell TransplantationBone and BonesTransplantation ConditioningAnemia, AplasticLeukemiaTransplantation ChimeraLiver TransplantationCyclophosphamideTissue DonorsBusulfanGraft SurvivalCombined Modality TherapyBone Marrow PurgingHistocompatibility TestingTreatment OutcomeHistocompatibilityHematopoietic Stem CellsTransplantation, IsogeneicBone Marrow DiseasesRecurrenceKidney TransplantationHematopoiesisLeukemia, Myeloid, AcuteHematologic NeoplasmsTime FactorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMice, Inbred C57BLPrecursor Cell Lymphoblastic Leukemia-LymphomaSurvival AnalysisRadiation ChimeraBone Marrow ExaminationImmunosuppressive AgentsHepatic Veno-Occlusive DiseaseRemission InductionLymphoma, Non-HodgkinGraft RejectionLeukemia, MyeloidChemotherapy, AdjuvantBone RemodelingStem Cell TransplantationBone Marrow NeoplasmsTransplantation ImmunologyAcute DiseaseDisease-Free SurvivalImmunosuppressionSurvival RateGraft vs Host ReactionLymphocyte DepletionLeukocyte TransfusionEtoposideHeart TransplantationHematologic DiseasesMyelodysplastic SyndromesSevere Combined ImmunodeficiencyT-LymphocytesFollow-Up StudiesRetrospective StudiesHLA AntigensActuarial AnalysisColony-Forming Units AssayCytarabineCarmustinePrognosisChimeraLung TransplantationAntineoplastic AgentsCyclosporineLymphocyte TransfusionMelphalanBone DensityGranulocyte Colony-Stimulating FactorGraft vs Leukemia EffectGraft vs Tumor EffectMethotrexateOrgan TransplantationNuclear FamilyLymphomaLeukocyte CountPancytopeniaCytomegalovirus InfectionsHodgkin DiseaseCell DifferentiationMultiple MyelomaMice, Inbred BALB CFatal OutcomeFlow CytometryDoxorubicinSpleenBone ResorptionBone NeoplasmsSalvage TherapyProspective Studies